EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
05/29/2025
Back to search
Official data from USPTO
PURESPRING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
06/04/2025
Classification
Registered
Trademark type
Combined
Nice classes
5, 42, 44
Filing date
11/09/2021
Registration date
12/12/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/12/2023
Last transaction
06/04/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
GB
Examiner
DUBIN, DAVID
Law office
L70
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of of the stylized teal wording "PURESPRING" in which the tittle above the letter "I" is featured in green. The stylized wording, as illustrated in the mark, is featured on top of a white rectangular background.
Holders and representatives
Holders
Purespring Therapeutics Limited
Representatives
Ben Natter Haug Partners, LLP
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Gene therapy therapeutic productspharmaceutical and medical preparations for treating kidney disease
Class 42
Pharmaceuticalmedical and scientific research and scientific research information in the field of gene therapy for kidney diseases; Scientific research in the field of gene therapy; Medicalpharmaceutical and scientific research services for assessing the efficiency of pharmaceutical and medical preparations and substances; Medical and scientific researchconducting clinical trials for others
Class 44
Pharmaceutical advice and medical services; medical diagnostic and screening servicesmedical diagnostic testingmonitoring and reporting services for diagnostic or treatment purposes; healthcare services; advisory services in the fields of medicine and pharmacologymedical advisory services; consultancy and information services relating to pharmaceutical and medical preparations and substancespharmaceutical advice and medical advisory services
Publications
History of USPTO decisions and trademark events.
45 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
05/29/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/29/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/29/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
05/29/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
05/29/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
03/14/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/27/2024
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/02/2024
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/13/2024
FIMP
FINAL DISPOSITION PROCESSED
03/13/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/12/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/12/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
12/12/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/16/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
11/16/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
11/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/26/2023
PUBO
PUBLISHED FOR OPPOSITION
09/26/2023
GPNX
NOTIFICATION PROCESSED BY IB
09/25/2023
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/16/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/06/2023
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/06/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/06/2023
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/30/2023
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/24/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/23/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/23/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/23/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/23/2023
GNFR
FINAL REFUSAL E-MAILED
05/23/2023
CNFR
FINAL REFUSAL WRITTEN
05/23/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/07/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/07/2023
RFNT
REFUSAL PROCESSED BY IB
11/08/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/17/2022
RFRR
REFUSAL PROCESSED BY MPU
10/17/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/26/2022
CNRT
NON-FINAL ACTION WRITTEN
08/25/2022
DOCK
ASSIGNED TO EXAMINER
08/19/2022
MAFR
APPLICATION FILING RECEIPT MAILED
03/29/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/25/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/24/2022
Continuous trademark protection
Get notified about every new filing that threatens PURESPRING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.